1. Home
  2. GRI vs NCL Comparison

GRI vs NCL Comparison

Compare GRI & NCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

HOLD

Current Price

$2.37

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Logo Northann Corp.

NCL

Northann Corp.

HOLD

Current Price

$0.17

Market Cap

3.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRI
NCL
Founded
2018
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.7M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
GRI
NCL
Price
$2.37
$0.17
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$160.00
N/A
AVG Volume (30 Days)
31.4K
166.8K
Earning Date
05-14-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.43
EPS
N/A
N/A
Revenue
N/A
$15,349,854.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.86
52 Week Low
$0.18
$0.10
52 Week High
$6.70
$1.47

Technical Indicators

Market Signals
Indicator
GRI
NCL
Relative Strength Index (RSI) 46.45 54.17
Support Level $2.16 $0.16
Resistance Level $2.66 $0.17
Average True Range (ATR) 0.19 0.02
MACD -0.03 0.00
Stochastic Oscillator 30.71 91.88

Price Performance

Historical Comparison
GRI
NCL

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

About NCL Northann Corp.

Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. It offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, mainly through its sales network in North America and Europe.

Share on Social Networks: